FDA Warns Actos Patients to Beware of Risk
Actos (pioglitazone), the medication frequently prescribed to Type 2 diabetes patients in order to decrease their insulin resistance, is a dangerous drug. Sold as a single ingredient product under the brand name Actos or sold in combination with metformin and glimepiride, pioglitazone treatments substantially increase the risk that patients develop bladder cancer, according to the Food and Drug Administration (FDA).
The risk of Actos-induced bladder cancer is particularly prominent among patients who take pioglitazone treatments for longer than one year. If you’ve noticed symptoms of bladder cancer such as red color urine, urgent urination, or painful urination, you should talk to a trusted medical professional as soon as possible.
You should also speak with the legal professionals at Fears Nachawati. With years of experience protecting victims and fighting for their legal interests, our specialization in the law governing dangerous drugs prepares us to help you and your family. The consultation with our attorneys is free and the advice could give you the clarity and peace of mind you’ve been looking for. Call us today at 1.866.545.8364 or email email@example.com. We’re ready to fight for you!